Biological effects of resveratrol

Antioxidants and Redox Signaling

Volumn 3, Issue 6, 2001, Pages 1041-1064

  Bhat, K P L ^a   Kosmeder II, J W ^a   Pezzuto, J M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PHYTOALEXIN; RESVERATROL;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; CANCER PREVENTION; CONTROLLED STUDY; ESTROGEN ACTIVITY; GRAPE; HEART PROTECTION; HUMAN; HUMAN CELL; MOUSE; NEUROPROTECTION; NONHUMAN; PEANUT; PRIORITY JOURNAL; RAT; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; WINE;

ANIMALIA; ARACHIS HYPOGAEA; VITIS SP.;

EID: 0035663191     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601317203567     Document Type: Review

References (148)

1. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism
2. Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects
3. In vitro response of human gingival epithelial S-G cells to resveratrol
4. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
5. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons
6. 0-ATPase, early target of the radical initiator 2,2′-azobis-(2-amidinopropane) dihydrochloride in rat liver mitochondria in vitro
7. Interaction of trans-resveratrol with plasma proteins
8. Resveratrol inhibits metal ion-dependent and -independent peroxidation of porcine low-density lipoproteins
9. Clinical chemoprevention: Developing a cancer prevention strategy
10. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C 7H2 leukemia cells
11. Antiplatelet activity of synthetic and natural resveratrol in red wine
12. Antiplatelet activity of cis-resveratrol
13. Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: A co-factor in anti-inflammatory and anticancer chemopreventive activity
14. Stimulation of endogenous adenosine release by oral administration of quercetin and resveratrol in man
15. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β
16. Does resveratrol induce pharmacological preconditioning?
17. Iron absorption and phenolic compound: Importance of different phenolic structures
18. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions
19. Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress
20. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: Evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action
21. 3
22. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
23. Resveratrol, a natural product present in wine, decreases tumor growth in a rat tumor model
24. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity
25. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway
26. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta
27. Anti-allergic action of resveratrol and related hydroxystilbenes
28. Resveratrol is a selective human cytochrome 450 1A1 inhibitor
29. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol
30. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
31. Alcohol, ischemic heart disease, and the French paradox
32. Alcohol, ischemic heart disease, and the French paradox
33. Phytoalexin production potential of grape berries
34. Cardioprotection of red wine: Role of polyphenolic antioxidants
35. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines
36. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries
37. Nutritional antioxidants as antidegenerative agents
38. Trans-resveratrol inhibits calcium influx in thrombin-stimulated human platelets
39. Resveratrol inhibition of herpes simplex virus replication
40. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease
41. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation
42. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: Reversal of endothelin-1 stimulatory effects
43. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium
44. Phytoalexin resveratrol (3,4′,5-trihydroxystilbene) modulates granulocyte and monocyte endothelial adhesion
45. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
46. Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury
47. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids
48. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
49. Resveratrol as a new type of DNA-cleaving agent
50. The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase Cα activity
51. Resveratrol selectively inhibits leukemia cells: A prospective agent for ex vivo bone marrow purging
52. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
53. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol
54. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production
55. Benefits of elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma
56. Disease resistance results in foreign phytoalexin expression in a novel plant
57. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors as benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone-induced lung tuomorigenesis in A/J mice
58. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase
59. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
60. Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by androgen receptor (AR)-independent mechanism
61. 2
62. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
63. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes
64. Primary mutagenicity screening of food additives currently used in Japan
65. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries
66. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production
67. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin
68. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
69. Kinase inhibitors from Polygonum cuspidatum
70. Programmed cell death regulation: Basic mechanisms and therapeutic opportunities
71. Paradoxical effects of resveratrol on the two prostaglandin H synthases
72. Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: Electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism
73. Effect of antioxidants, resveratrol, quercetin and N-acetylcysteine, on the functions of cultured rate hepatic stellate cells and Kupffer cells
74. Effects of stilbenes on arachidonate metabolism in leukocytes
75. Resveratrol decreases early signaling events in washed platelets but has little effect on platalet in whole food
76. Rational design of potent human transthyretin amyloid disease inhibitors
77. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the "French paradox"?
78. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a reponse to infection or injury
79. Identification of pterostilbene as a phytoalexin from Vitis vinifera leaves
80. Illustration of analysis taking into account complex survey considerations: The association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid
81. + current in vascular endothelial cells
82. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
83. Involvement of 5-lipoxygenase in programmed cell death of cancer cells
84. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
85. Resveratrol inhibits the growth of Helicobacter pylori in vitro
86. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-KB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation
87. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production
88. Chemotherapeutic drug-induced apoptosis in human leukemic cells is independent of Fas (APO-1/CD95) receptor/ligand system
89. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice
90. Class A scavenger up-regulation in smooth muscle cells by oxidized low density lipoprotein
91. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
92. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells
93. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats
94. Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats
95. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth
96. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure
97. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs
98. Resveratrol reverses tumor-promoter-induced inhibition of gapjunctional intercellular communication
99. Inhibitory effect of resveratrol on free radical generation in blood platelets
100. Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area
101. Wines and grape juices as modulators of platelet aggregation in healthy human subjects
102. Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis
103. Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India
104. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine
105. 2 phase transition
106. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
107. Calcium signaling in human platelets
108. Synergistic induction of cyclooxygenase-2 by transforming growth factor-betal and epidermal growth factor inhibits apoptosis in epithelial cells
109. Relation of 8-hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate
110. Myocardial protection with red wine extract
111. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells
112. Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles
113. Oxyresveratrol as the potent inhibitor of dopa oxidase activity of mushroom tyrosinase
114. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol
115. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
116. Resveratrol: A molecule whose time has come? and gone?
117. Wine as a biological fluid: History, production, and role in disease prevention
118. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line
119. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism
120. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases. Inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation
121. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
122. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia
123. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
124. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances
125. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells
126. Formaldehyde generators and capturers as influencing factors of mitotic and apoptotic processes
127. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures
128. Resveratrol inhibition of lipid peroxidation
129. Modulation by phytochemicals of cytochrome P450-linked enzyme activity
130. CIP expression
131. Resveratrol, MAP kinases and neuronal cells: Might wine be a neuroprotectant?
132. Resveratrol: Isomeric molar absorptivities and stability
133. Suppression of nitric oxide synthase and down-regulation of the activation of NFκB in macrophages by resveratrol
134. Resveratrol induces Fas signaling-independent apoptosis in THP-1 human monocytic leukemia cells
135. Is resveratrol an estrogen agonist in growing rats?
136. Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats
137. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants
138. Effects of wine polyphenolics quercetine and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages
139. The role of COX-2 in intestinal cancer
140. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits
141. Nicotine inhibition of apoptosis suggests a role in tumor promotion
142. Ligand structure-dependent differences in activation of estrogen receptor α in human HepG2 liver and U2 osteogenic cancer cell lines
143. Antioxidants with carcinostatic activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion
144. 1-ATPase/ATP synthase by polyphenolic phytochemicals
145. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice
146. Effects of resveratrol on the rat brain respiratory chain
147. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells
148. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein